EFFICACY OF MICROTUBULE-ACTIVE DRUGS FOLLOWED BY KETOCONAZOLE IN HUMAN METASTATIC PROSTATE CANCER CELL LINES
- 1 March 2000
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cellsLeukemia, 1999
- Microtubules and actin filaments: dynamic targets for cancer chemotherapyCurrent Opinion in Cell Biology, 1998
- Synergistic Induction of HL60 Cell Differentiation by Ketoconazole and 1-Desoxy Analogues of Vitamin D3JNCI Journal of the National Cancer Institute, 1997
- In vitro effect of gallium nitrate when combined with ketoconazole in the prostate cancer cell line PC-3Cancer Letters, 1997
- Symptomatic Improvement Associated With Combined Estramustine and Vinblastine Chemotherapy for Metastatic Prostate CancerAmerican Journal of Clinical Oncology, 1996
- Inactivation of Bcl-2 by phosphorylation.Proceedings of the National Academy of Sciences, 1995
- Paclitaxel (Taxol)New England Journal of Medicine, 1995
- In vitro antitumor effect of hydroxyurea on hormone-refractory prostate cancer cells and its potentiation by phenylbutyrateAnti-Cancer Drugs, 1994
- Management of relapsing disease in prostate cancerCancer, 1992
- Ketoconazole: A Possible Direct Cytotoxic Effect on Prostate Carcinoma CellsJournal of Urology, 1989